No fees unless we win.
Get a free consultation
8 Reviews
5.0
★★★★★

FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death

Reuters (9/27, Clarke), the AP (9/27) and the Wall Street Journal (9/27) reported on Friday that the Food and Drug Administration issued a warning that tigecycline (Tygacil), Pfizer Inc’s antibacterial drug, can increase the risk of death when used as authorized by the FDA or for other non-approved conditions.  A boxed warning will be added to the drug’s label, and the FDA indicated the drug should be used only in situations where no other treatment options are available.

The drug is approved to treat complicated skin and abdominal infections and community-acquired bacterial pneumonia. It is not approved to treat diabetic foot infection or hospital-acquired pneumonia.

Zoll, Kranz & Borgess, LLC (“ZKB”) specializes in assisting individuals injured or killed from dangerous, defective or contaminated medical drugs and devices.  For more information, contact our pharmaceutical drug and device litigation attorneys by calling toll-free 888-841-9623.

Published by:
Share
Picture of Michelle L. Kranz
Michelle L. Kranz

Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.

Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.

Additional Dangerous Drugs resources on our website:
All
FAQs
Injuries & Conditions
Legal Help
Other Resources
Settlements & Compensation
You can learn more about this topic by visiting any of our Pradaxa Lawsuit pages listed below:
Boehringer Ingelheim Fined $931,000 For Withholding Evidence
Break in Pradaxa Case: Judge Rejects Protective Order from Pharmaceutical Company
Daughters File Pradaxa Lawsuit Over Mother’s Death
Family Files Pradaxa Lawsuit After Woman Suffers Massive Hemorrhaging
FDA to Conduct Pradaxa Study
First Phase of Pradaxa Settlement Funds Ordered to Be Set Aside
Has Pradaxa Been Linked to Major Bleeding Events?
How Many Patients Died in a Trial Study of Pradaxa?
Is Pradaxa Safe to Prescribe to Patients?
Loved One Died After Taking Pradaxa? Penn. Widow Files Wrongful Death Lawsuit
Over 2,000 Lawsuits Filed Over Blood Thinner, Pradaxa
Pradaxa Adverse Events Extremely High According to Reporting System
Pradaxa Approved to Treat VTE, Concerns Linger
Pradaxa is the Most Complained About Drug in the Country
Pradaxa Lawsuits Expected to Begin in August
Pradaxa Settlement Announced to be a Potential $650 Million Deal
Should I Take Pradaxa?
Do you have a case?

A serious injury can have life-altering results.

Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.

8 Reviews
5.0
★★★★★
Recovered damages
$35 Million+

Table of Contents

Practice Areas
About Zoll & Kranz, LLC

For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.

Do you believe you’re entitled to compensation?

Use our Instant Case Evaluator to find out in as little as 60 seconds!

Guides & Resources

Other Pradaxa Lawsuit Resources

All
FAQs
Injuries & Conditions
Legal Help
Other Resources
Settlements & Compensation